Melasma / Chloasma (Hyperpigmentation) Treatment
Covered by Aetna in California

Triple combination cream approach (FDA-approved formulation: fluocinolone acetonide 0.01% / hydroquinone 4% / tretinoin 0.05% — brand Tri-Luma) twice daily × 8 weeks then maintenance; OR de-constructed approach: tretinoin 0.025–0.05% cream nightly + hydroquinone 4% cream twice daily + low-potency steroid short-term; broad-spectrum SPF 50+ sunscreen with iron oxide is essential and used twice daily — sun protection is the single most critical melasma intervention

Azelaic acid 15% gel (Finacea generic) twice daily — a non-hydroquinone, safer-for-darker-skin-tones option with evidence for melasma per AAD; kojic acid-based topicals; tranexamic acid oral 250 mg twice daily (off-label, not FDA-approved for melasma, but strong meta-analysis evidence — assess bleeding and clotting contraindications before prescribing); topical tranexamic acid 3–5% formulations (emerging, available through compounding pharmacies); cysteamine 5% cream (newer option, well-tolerated); adapalene 0.3% cream as a gentler retinoid for darker skin types (Fitzpatrick IV–VI) where tretinoin may cause irritation-triggered PIH

No — Aetna CA does not cover melasma treatments as they are classified as cosmetic. Self-pay: generic tretinoin $10–$40; azelaic acid 15% gel $20–$60; hydroquinone 4% cream $15–$50 (compounding pharmacies); oral tranexamic acid generic $15–$30/month at California pharmacies. TDMD visit: $49 self-pay.

Per AAD guidance (updated 2026 AAD DermWorld feature), first-line melasma therapy remains the triple combination cream (hydroquinone + tretinoin + topical steroid), but non-hydroquinone formulations (azelaic acid, tranexamic acid, kojic acid, cysteamine) are increasingly used as maintenance or first-line therapy in darker skin types due to the irritancy and ochronosis risk with prolonged hydroquinone. The AAD emphasizes that melasma is highly UV-driven and recurs without rigorous sun protection — treatment without diligent SPF 50+ (ideally with iron oxide for visible-light protection) provides minimal sustained benefit. Melasma worsens with oral contraceptives and hormonal changes; pregnancy (chloasma gravidarum) is a major precipitant.

Unfortunately, 'medically necessary' is not a criterion that overrides the cosmetic exclusion for melasma in standard Aetna CA commercial plans. The medical necessity clause applies to health conditions where treatment is required to prevent harm or treat disease — melasma, despite causing significant psychological distress, is classified by insurers as a cosmetic condition. No matter how well a physician documents the psychological impact or the prescription details, Aetna CA's benefit language excludes cosmetic indications. If you have concurrent acne and are prescribed tretinoin for acne as the primary indication, the pharmacy benefit may cover tretinoin under the acne indication — Dr. Bhavsar evaluates this honestly.

Melasma management for darker skin types (common in Latina patients, Fitzpatrick III–IV) requires a more cautious approach than for lighter skin. High-potency tretinoin can cause irritant dermatitis, which itself triggers post-inflammatory hyperpigmentation in darker skin — worsening the appearance. Dr. Bhavsar would typically start with adapalene 0.3% cream (gentler than tretinoin) or azelaic acid 15% gel, combined with rigorous daily sunscreen use (SPF 50+ with iron oxide — iron oxide blocks visible light, which also contributes to melasma in darker skin). Hydroquinone 4% can be used intermittently but should not be used long-term (>3–4 months) without breaks. Triple combination cream is highly effective but should be used for 8 weeks with maintenance rather than continuously.

Yes — oral tranexamic acid (250 mg twice daily, off-label) has strong evidence from multiple RCTs and meta-analyses for melasma and is increasingly used when topical therapy alone is insufficient. Dr. Bhavsar can prescribe it after reviewing contraindications: personal or family history of thrombosis (DVT, PE, stroke), concurrent hormonal contraceptive use (combined estrogen + TXA increases clot risk), and renal function. Generic oral tranexamic acid is available at California pharmacies for approximately $15–$30/month. It is not FDA-approved for melasma (FDA-approved only for heavy menstrual bleeding and hereditary angioedema in certain forms), and Aetna CA will not cover it for this cosmetic indication — it is a self-pay medication for this use.

Yes. Aetna commercial plans cover telehealth visits for Melasma / Chloasma (Hyperpigmentation) in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your melasma treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your melasma treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.